Actively Recruiting
Normalizing Antibody Detection in First-void Urine
Led by Universiteit Antwerpen · Updated on 2024-09-03
150
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
Sponsors
U
Universiteit Antwerpen
Lead Sponsor
U
University Hospital, Antwerp
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this study is to develop robust analytical protocols for the monitoring of vaccine induced immunity against the Human Papillomavirus (HPV) in first-void urine samples and to examine fluctuations of urinary HPV-specific antibodies and potential normalization markers in different cohorts.
CONDITIONS
Official Title
Normalizing Antibody Detection in First-void Urine
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Vaccinated with either the Cervarix, Gardasil or Gardasil9 HPV-vaccine and able to present vaccination booklet or another official document proving this.
- Able to understand the information brochure and what the study is about.
- Willing to give informed consent to contact his/her general practitioner and/or gynecologist to access details on their HPV vaccination schedule and, in case a woman within the screening population, cervical cancer screening results (smears, HPV tests, colposcopy, biopsy).
You will not qualify if you...
- Participating in another clinical trial at the same time of participating in this study.
- Women that underwent hysterectomy or were treated for cervical (pre)cancer lesions within the six months prior to study enrolment.
- Pregnant women.
- Being positive for Human Immunodeficiency Virus (HIV), Hepatitis B or Hepatitis C.
- Having a history or current evidence of any condition or abnormality that might confound the results of the study or is not in the best interest of the individual to participate, in the opinion of the investigator.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Antwerp
Edegem, Antwerp, Belgium, 2650
Actively Recruiting
Research Team
A
Alex Vorsters, Professor
CONTACT
M
Margo Bell
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here